Highlights and Quick Summary
- Depreciation & Amortization for the quarter ending December 31, 2022 was $41 Thousand (a -2.38% decrease compared to previous quarter)
- Year-over-year quarterly Depreciation & Amortization decreased by -24.07%
- Annual Depreciation & Amortization for 2022 was $167 Thousand (a -57.4% decrease from previous year)
- Annual Depreciation & Amortization for 2022 was $392 Thousand (a 69.7% increase from previous year)
- Annual Depreciation & Amortization for 2021 was $231 Thousand (a -45.52% decrease from previous year)
- Twelve month Depreciation & Amortization ending December 31, 2022 was $143 Thousand (a -8.92% decrease compared to previous quarter)
- Twelve month trailing Depreciation & Amortization decreased by -32.86% year-over-year
Trailing Depreciation & Amortization for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| $143 Thousand | $157 Thousand | $167 Thousand | $213 Thousand |
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Depreciation & Amortization of Benitec Biopharma Limited
Most recent Depreciation & Amortizationof BNTC including historical data for past 10 years.Interactive Chart of Depreciation & Amortization of Benitec Biopharma Limited
Benitec Biopharma Limited Depreciation & Amortization for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $0.04 | $0.04 | $0.01 | $0.05 | $0.17 |
| 2021 | $0.06 | $0.05 | $0.05 | $0.07 | $0.23 |
| 2020 | $0.07 | $0.05 | $0.04 | $0.15 | $0.19 |
| 2019 | – | – | $0.1 | $0.05 | $0.16 |
| 2018 | – | – | – | – | $0.15 |
| 2017 | – | – | – | – | $0.16 |
| 2016 | – | – | – | $0.21 | $0.21 |
| 2015 | – | – | – | $0.08 | $0.08 |
| 2014 | – | – | – | $0.01 | $0.01 |
| 2013 | $0.03 | – | – | – | $0.03 |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology